Estimated Medicare Part B Savings From Inflationary Rebates
JAMA · 2023
DOI: 10.1001/jama.2022.20189 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Alexander C Egilman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program on Regulation, Therapeutics, and Law (PORTAL), Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Cost Savings, Drug Costs, Medicare Part B, Medicare Part D. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study uses annual Medicare Part B spending data to examine the potential savings from the drug pricing reforms in the Inflation Reduction Act of 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program on Regulation, Therapeutics, and Law (PORTAL), Brigham and Women's Hospital, Boston, Massachusetts.
Zitieren
APA
Egilman, A. C., Kesselheim, A. S., & Rome, B. N. (2023). Estimated Medicare Part B Savings From Inflationary Rebates. JAMA. https://doi.org/10.1001/jama.2022.20189
Vancouver
Egilman AC, Kesselheim AS, Rome BN. Estimated Medicare Part B Savings From Inflationary Rebates. JAMA. 2023. doi:10.1001/jama.2022.20189
BibTeX
@article{Egilman2023,
author = {Egilman, Alexander C and Kesselheim, Aaron S and Rome, Benjamin N},
title = {Estimated Medicare Part B Savings From Inflationary Rebates},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2022.20189}
}
EUVIMED